Evaluation of a new dual-specificity promoter for selective induction of apoptosis in breast cancer cells (original) (raw)

• Roth J, Cristiano R . Gene therapy for cancer: what have we done and where are we going? J Natl Cancer Inst 1997; 89:: 21–39
  Article Google Scholar
• Dranoff G . Cancer gene therapy: connecting basic research with clinical inquiry J Clin Oncol 1998; 16:: 2548–2556
  Article Google Scholar
• Hart I . Tissue-specific promoters in targeting systemically delivered gene therapy Semin Oncol 1996; 23:: 154–158
  Google Scholar
• Kanai F, Lan K, Shiratori Y, et al . In vivo gene therapy for α-Fetoprotein–producing hepatocellular carcinoma by adenovirus-mediated transfer of cytosine deaminase gene Cancer Res 1997; 57:: 461–465
  Google Scholar
• Cao G, Kuriyama S, Gao J, et al . Effective and safe gene therapy for colorectal carcinoma using the cytosine deaminase gene directed by the carcinoembryonic antigen promoter Gene Ther 1999; 6:: 83–90
  Article Google Scholar
• Lan K, Kanai F, Shiratori Y, et al . In vivo selective gene expression and therapy mediated by adenoviral vectors for human carcinoembryonic antigen-producing gastric carcinoma Cancer Res 1997; 57:: 4279–4284
  Google Scholar
• Hallenbeck P, Chang Y, Hay C, et al . A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma Hum Gene Ther 1999; 10:: 1721–1733
  Article Google Scholar
• Yu D, Sakamoto GT, Henderson DR . Identification of the transcriptional regulatory sequences of human Kallikrein 2 and their use in the construction of Calydon Virus 764, an attenuated replication-competent adenovirus for prostate cancer therapy Cancer Res 1999; 59:: 1498–1504
  Google Scholar
• Cao G, Zhang X, He X, et al . A safe, effective in vivo gene therapy for melanoma using tyrosinase promoter-driven cytosine deaminase gene In Vivo 1999; 13:: 181–187
  Google Scholar
• Cheon J, Ko S, Gardner T, et al . Chemogene therapy: osteocalcin promoter-based suicide gene therapy in combination with methotrexate in a murine osteosarcoma model Cancer Gene Ther 1997; 4:: 359–365
  Google Scholar
• Anderson LM, Swaminathan S, Zackon I, et al . Adenovirus-mediated tissue-targeted expression of the HSVtk gene for the treatment of breast cancer Gene Ther 1999; 6:: 854–864
  Article Google Scholar
• Anderson LM, Krotz S, Weitzman, et al . Breast cancer-specific expression of the Candida albicans cytosine deaminase gene using a transcriptional targeting approach Cancer Gene Ther 2000; 7:: 845–852
  Article Google Scholar
• Brugger W, Buhring HJ, Grunebach F, et al . Expression of MUC-1 epitopes on normal bone marrow: implications for the detection of micrometastatic tumor cells J Clin Oncol 1999; 17:: 1535–1544
  Article Google Scholar
• Kurihara T, Brough DE, Kovesdi I, et al . Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC-1 antigen J Clin Invest 2000; 106:: 763–771
  Article Google Scholar
• Hernandez-Alcoceba R, Pihalja M, Wicha MS, et al . A novel, conditionally replicative adenovirus for the treatment of breast cancer that allows controlled replication of E1a-deleted adenoviral vectors Hum Gene Ther 2000; 11:: 2009–2024
  Article Google Scholar
• Ekena K, Katzenellenbogen JA, Katzenellenbogen BS . Determinants of ligand specificity of estrogen receptor-α: estrogen versus androgen discrimination J Biol Chem 1998; 273:: 693–699
  Article Google Scholar
• Valavaara R . Reliability of estrogen receptors in predicting response to antiestrogens Oncology 1997; 11:: 14–18
  Google Scholar
• Zhong H, De Marzo AM, Laughner E, et al . Overexpression of hypoxia-inducible factor 1 alpha in common human cancers and their metastases Cancer Res 1999; 59:: 5830–5835
  Google Scholar
• Talks KL, Turley H, Gatter KC, et al . The expression and distribution of the hypoxia-inducible factors HIF-1 alpha and HIF-2 alpha in normal tissues, cancers, and tumor-associated macrophages Am J Pathol 2000; 157:: 411–421
  Article Google Scholar
• Bunn HF, Poyton R . Oxygen sensing and molecular adaptation to hypoxia Physiol Rev 1996; 76:: 839–879
  Article Google Scholar
• Maxwell PH, Dachs GU, Gleadle JM, et al . Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth Proc Natl Acad Sci USA 1997; 94:: 8104–8109
  Article Google Scholar
• Ryan HE, Poloni M, McNulty W, et al . Hypoxia-inducible factor-1 alpha is a positive factor in solid tumor growth Cancer Res 2000; 60:: 4010–4015
  Google Scholar
• Dachs GU, Patterson AV, Firth JD, et al . Targeting gene expression to hypoxic tumor cells Nat Med 1997; 3:: 515–520
  Article Google Scholar
• Ruan H, Wang J, Hu L, et al . Killing of brain tumor cells by hypoxia-responsive element–mediated expression of BAX Neoplasia 1999; 1:: 431–437
  Article Google Scholar
• Modlich U, Pugh CW, Bicknell R . Increasing endothelial cell–specific expression by the use of heterologous hypoxic and cytokine-inducible enhancers Gene Ther 2000; 7:: 896–902
  Article Google Scholar
• Green DR . Apoptotic pathways: paper wraps stone blunts scissors Cell 2000; 102:: 1–4
  Article Google Scholar
• Adams JM, Cory S . The Bcl-2 protein family: arbiters of cell survival Science 1998; 281:: 1322–1326
  Article Google Scholar
• Gibson LF, Fortney J, Magro G, et al . Regulation of BAX and BCL-2 expression in breast cancer cells by chemotherapy Breast Cancer Res Treat 1999; 55:: 107–117
  Article Google Scholar
• Clarke M, Apel I, Benedict M, et al . A recombinant bcl-xs adenovirus selectively induces apoptosis in cancer cells but not in normal bone marrow cells Proc Natl Acad Sci USA 1995; 92:: 11024–11028
  Article Google Scholar
• Ealovenga M, McGinnis P, Sumantran V, Clarke M, Wicha M . Bcl-xs gene therapy induces apoptosis of human mammary tumors in nude mice Cancer Res 1996; 56:: 1965–1969
  Google Scholar
• Shinoura N, Muramatsu Y, Yoshida Y, et al . Adenovirus-mediated transfer of caspase-3 with Fas ligand induces drastic apoptosis in U373MG glioma cells Exp Cell Res 2000; 256:: 423–433
  Article Google Scholar
• Inohara N, Ding L, Chen S, et al . Harakiri, a novel regulator of cell death, encodes a protein that activates apoptosis and interacts selectively with survival-promoting proteins Bcl-2 and Bcl-X L EMBO J 1997; 16:: 1686–1694
  Article Google Scholar
• Montano MM, Ekena K, Krueger KD, et al . Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens Mol Endocrinol 1996; 10:: 230–242
  Google Scholar
• Aoki K, Barker C, Danthinne X, et al . Efficient generation of recombinant adenoviral vectors by Cre–Lox recombination in vitro Mol Med 1999; 5:: 224–231
  Article Google Scholar
• Vassaux G, Hurst HC, Lemoine NR . Insulation of a conditionally expressed transgene in an adenoviral vector Gene Ther 1999; 6:: 1192–1197
  Article Google Scholar
• Shi Q, Wang Y, Worton R . Modulation of the specificity and activity of a cellular promoter in an adenoviral vector Hum Gene Ther 1997; 8:: 403–410
  Article Google Scholar
• Carmichael J, DeGraff WG, Gazdar AF, et al . Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing Cancer Res 1987; 47:: 936–942
  Google Scholar
• Nieves-Neira W, Pommier Y . Apoptotic response to campothecin and 7-hydroxystaurosporine (UCN-01) in the 8 human breast cancer cell lines of the NCI anticancer drug screen: multifactorial relationships with topoisomerase I, protein kinase C, Bcl-2, p53, MDM-2, and caspase pathways Int J Cancer 1999; 82:: 396–404
  Article Google Scholar
• Peng K, Vile R . Vector development for cancer gene therapy Tumor Targeting 1999; 4:: 3–11
  Google Scholar
• Hermiston T . Gene delivery from replication-selective viruses: arming guided missiles in the war against cancer J Clin Invest 2000; 105:: 1169–1172
  Article Google Scholar
• Velculescu V, Zhang L, Vogelstein B, et al . Serial analysis of gene expression Science 1995; 270:: 484–487
  Article Google Scholar
• Nacht M, Ferguson AT, Zhang W, et al . Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer Cancer Res 1999; 59:: 5464–5470
  Google Scholar
• Nettelbeck DM, Jerome V, Muller R . A dual-specificity promoter system combining cell cycle–regulated and tissue-specific transcriptional control Gene Ther 1999; 6:: 1276–1281
  Article Google Scholar
• Motoi F, Sunamura M, Ding L, et al . Effective gene therapy for pancreatic cancer by cytokines mediated by restricted replication-competent adenovirus Hum Gene Ther 2000; 11:: 223–235
  Article Google Scholar